News
HLN
9.25
+0.49%
0.05
Weekly Report: what happened at HLN last week (0511-0515)?
Weekly Report · 2d ago
Bernstein Reaffirms Their Hold Rating on Haleon PLC (HLN)
TipRanks · 05/13 03:20
Haleon releases transcript of Q1 2026 trading update call
PUBT · 05/11 15:32
Weekly Report: what happened at HLN last week (0504-0508)?
Weekly Report · 05/11 09:56
Haleon PLC (HLN) Gets a Buy from Barclays
TipRanks · 05/11 08:07
Jefferies Reaffirms Their Buy Rating on Haleon PLC (HLN)
TipRanks · 05/05 13:15
Haleon launches reformulated Centrum Adults 50+ multivitamin in Canada
PUBT · 05/04 11:03
Weekly Report: what happened at HLN last week (0427-0501)?
Weekly Report · 05/04 09:55
Kepler Capital Sticks to Its Buy Rating for Haleon PLC (HLN)
TipRanks · 05/01 01:54
Haleon price target lowered to 325 GBp from 350 GBp at Deutsche Bank
TipRanks · 04/30 18:28
Berenberg Bank Sticks to Its Buy Rating for Haleon PLC (HLN)
TipRanks · 04/30 13:43
UBS Reaffirms Their Buy Rating on Haleon PLC (HLN)
TipRanks · 04/30 09:11
Haleon PLC (HLN) Gets a Buy from Goldman Sachs
TipRanks · 04/30 08:47
Barclays Sticks to Its Buy Rating for Haleon PLC (HLN)
TipRanks · 04/30 08:38
Haleon: Resilient Fundamentals and Strong Oral Health Growth Support Buy Rating and Unchanged $440 Price Target
TipRanks · 04/29 11:16
Haleon: Resilient Core Growth and Attractive Valuation Prompt Buy Rating, Price Target Maintained at $450
TipRanks · 04/29 08:26
HALEON CEO: IN MIDDLE EAST SEEING CONSUMPTION DOWN DOUBLE DIGIT BUT BELOW TEENS- CONF CALL
Reuters · 04/29 08:09
HALEON CEO: OPEN AND ACTIVELY LOOKING AT OPPORTUNITIES TO BRING IN HIGHER GROWTH ASSETS AND POTENTIALLY DIVESESTING NON CORE ASSETS - CONF CALL
Reuters · 04/29 08:09
HALEON CFO: HAVE STARTED TO SEE SURCHARGES TO FREIGHT, WOULD EXPECT THAT TO INCREASE- CONF CALL
Reuters · 04/29 08:09
HALEON CFO: MONITORING MIDDLE EAST CONFLICT CLOSELY, NO IMPACT ON FIRST QUARTER PERFORMANCE - CONF CALL
Reuters · 04/29 08:09
More
Webull provides a variety of real-time HLN stock news. You can receive the latest news about Haleon through multiple platforms. This information may help you make smarter investment decisions.
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.